Transformation of primary rodent cells by functions of the adenovirus type 12 (Ad12) early region 1 (E1) is reduced severalfold compared with transformation by E1 of Ad2. We analyzed whether the unique spacer region of Ad12 E1A that borders the conserved region (CR) 2 and represents an oncogenic determinant of Ad12 E1A is involved in this impaired transformation property, putatively by modulating transformation-relevant biological E1A functions. We show that a mutant (E1A Spm1 ) that lacks 12 amino-terminal residues of the spacer binds p105-Rb and p130 as Ad12 E1A wild type (E1A wt ), whereas a second spacer mutant (E1A Spm2 ) that lacks an adjacent stretch of six alanines exhibits highly reduced binding to p105-Rb. The binding of this mutant to the p130 pocket protein is, however, little impaired. E1A Spm1 diminishes the formation of the p105-Rb-E2F complex more efficiently than E1A wt or, least efficient, E1A Spm2 . These properties of the spacer mutants to target and to disintegrate the p105-Rb-E2F complex correspond with their ability to transform primary mouse cells in combination with E1B: E1A Spm1 (plus Ad12 E1B)-transfected cells could be easily established as cell lines, comparable to Ad12 E1A wt -or Ad2 E1A wt -transfected cells. In contrast, cells transfected with E1A Spm2 or Ad12 E1A delCR2 (lacking the entire CR2) died within 6-10 weeks after replating, although foci were formed in all cases. Of note, the E1A Spm1 -transformed cells grow as fast as the Ad2 E1A wt -transformed cells, with a doubling rate of 15 h, whereas the doubling of the Ad12 E1A wt -transformed cells takes ϳ120 h. Moreover, in the established cell lines, the affinity of E1A Spm1 to p105-Rb was higher than with that of E1A wt. Our data suggest the presence of a transformation-suppressing domain within the carboxyl-terminal 12 residues of the Ad12 E1A-unique spacer, whereas the hydrophobic stretch of six alanines in the spacer is required for stable transformation.
INTRODUCTION
E1A oncoproteins from human adenoviruses (Ad) reprogram quiescent cells to progress from G 0 /G 1 to S phase, thereby overriding the growth suppressive signals of the untransformed cell (Jansen-Dürr, 1996) . This inappropriate up-regulation of the cell cycle can lead to mitosis and, especially in rodent cells, the transformation of the cells. Functions of E1A alone are able to immortalize primary rodent cells (Gallimore et al., 1985; Lynch and Trainer, 1989) , but in most cases the fully transformed phenotype can be achieved only by coexpression of a second oncogene, such as the activated cellular Ha-ras (Ruley 1983) or the adenoviral E1B (Williams et al., 1995) , that prevents E1A-induced apoptosis (White, 1995) .
Alternative splicing of the E1A transcription unit gives rise to five (Ad2/5) or six transcripts (Ad12; Brockmann and Esche, 1995) . From these, the functions of the 13S and 12S mRNA products are most frequently examined. E1A proteins do not bind DNA in a sequence-specific manner (Ferguson et al., 1985) . They mediate all of their known functions by physical interactions with cellular proteins, such as transcription factors/cofactors like activator protein-1, necrosis factor-B, ATF-2, p300, or TBP (Whyte et al., 1989; Lee et al., 1991; Wang et al., 1993; Geisberg et al., 1994; Zantema and van der Erb, 1995; Parker et al., 1997) or tumor suppressor proteins like p105-Rb (Nevins, 1995; Jones, 1995) . Most of these functions involve the nonconserved amino-terminus and/or the three conserved regions (CR) 1-3 of E1A that are highly homologous among different Ad serotypes. As a result of these interactions, E1A trans-regulates transcription of its own (Kirch et al., 1993; Kawamura et al., 1993; Pützer et al., 1997) and of other viral and cellular genes (Berk et al., 1979; Nevins, 1981; Shenk and Flint, 1991) . The interaction of E1A with the p105-Rb-E2F transrepressor complex (Weintraub et al., 1992) has drawn much attention and involves the CR1 and the CR2 (Dyson et al., 1992) : The CR2 domain was found to make the first contact between E1A and p105-Rb, allowing the CR1 to compete with E2F for the pocket protein binding (Ikeda and Nevins, 1993; Fattaey, 1993) . The released E2F transcription factor trans-activates several cellular genes (Bagchi et al., 1990) that are required for cell cycle progression, like DHFR (Slansky et al., 1993) , c-myc, and DNA-polymerase (Nevins, 1995) .
In contrast to the nononcogenic serotypes (e.g., Ad2), functions of the E1A plus E1B proteins of the oncogenic serotypes (e.g., Ad12) can induce tumors in immunocompetent rodents. The oncogenic determinants are located within the Ad12 E1A proteins (Williams et al., 1995) . Although functionally and structurally related, a considerable diversity evolved among the E1A genes of oncogenic and nononcogenic subgroups, especially when the nonconserved regions are considered (Brockmann and Esche, 1995) . Thus in contrast to the E1A proteins of Ad2, a p300-independent transcriptional trans-activation domain is located within the 29 amino acids of the amino-terminus (Lipinski et al., 1997) . Moreover, Ad12 E1A lacks two transcriptional activation domains (AR1 and AR2) that were found in Ad5 E1A to be involved in CR3-mediated transcriptional activation (Bondesson et al., 1992; Strom et al., 1998) . Another important difference is the presence of a unique spacer region in Ad12 E1A that is located between CR2 and CR3. It consists of a block of 20 amino acids that are not present in Ad2 E1A (Fig. 1A) and exhibit a considerable homology to transcriptional suppressor proteins found in the embryonic development of Drosophila (Licht et al., 1990) . Ad5/Ad12 hybrid virus experiments have shown that the integrity of the spacer is important for the oncogenicity of the virus (Jelinek et al., 1994; Telling and Williams, 1994) . Despite its additional oncogenic properties, the transformation rate of primary rat cells induced by transfection with Ad12 E1A/E1B was ϳ80% lower as for Ad2 E1A/Ad12 E1B (Leclére et al., 1993) . CR1 of Ad12 was found to be one determinant of the poor Ad12 E1A transformation properties. Interestingly, an Ad2/Ad12 E1A hybrid protein that contains the CR1 of Ad2 and the CR2 plus the spacer of Ad12 E1A was still 40% less efficient in transformation (Leclére et al., 1993) . The poor transformation property of Ad12 E1A corresponds with very recent results, where in contrast to Ad2 E1A, the expression of Ad12 E1A in human cells resulted in the prevention of mitosis by S-phase arrest (Grand et al., 1998) . Thus because CR2 is nearly identical between Ad12 and Ad2/5 E1A, a region carboxyl-terminal from the CR2, possibly the spacer, might be involved in the reduced transformation by Ad12 E1A.
Here we examined whether parts of the Ad12 E1A unique spacer modulate the CR2-dependent binding to p105-Rb or p130, the disruption of p105-Rb-and/or p130-E2F complexes, and a putative participation in the transformation of primary mouse cells. We provide evidence for two domains within the spacer that have different effects on the pocket protein interaction and transformation properties of Ad12 E1A. (Barbeau et al., 1994) are indicated. (B and C) Binding of the pocket proteins p105-Rb and p130 from 1 mg of (B) U937V or (C) A549 nuclear extracts to 50 g of different GST-Ad12 E1A fusion proteins were examined by combined protein interaction/Western blot experiments; one fourth of the nuclear proteins that bound to E1A (from 1 mg originally applied nuclear extract) was loaded onto the Western blot gel. The lanes A549 NE and U937V NE contain 20 g of nuclear extracts; GST alone indicates GST-tag without fused E1A proteins. The appearance of p105-Rb and p130 proteins on the blots is indicated. Rb, p130, and E1A were subsequently detected on the same blot. The intensive bands in case of the E1A antibody are due to the high levels of E1A, released from the GT-Sepharose.
The E1A proteins from the oncogenic Ad12 and the nononcogenic Ad2/5 exhibit differences in their interaction with cellular proteins, resulting in altered oncogenicity (Williams, 1995) , different transformation capacity in primary rodent cells (Leclé re et al., 1993) , and opposite ability to induce mitosis in quiescent human cells (Grand et al., 1998) . In the present study, we examined whether the Ad12 E1A unique spacer influences the targeting of the pocket proteins, the disruption of pocket protein-E2F complexes, or the transformation properties of Ad12 E1A.
The hydrophobic hexa-alanine stretch in the carboxylterminal half of the Ad12 E1A unique spacer region participates in the efficient binding of E1A to p105-Rb but not to p130
We analyzed the binding of GST-13S-E1A (E1A wt ) or spacer mutant fusion proteins (Fig. 1A) , immobilized on GT-Sepharose, to p105-Rb and p130 from nuclear extracts by in vitro protein interaction analysis and subsequent detection of E1A and the E1A-bound pocket proteins by Western blotting. Nuclear extracts were prepared from nearly confluent A549 cells or from U937V cells at a cell density of 2 ϫ 10 6 cells/ml medium. Under these conditions, p105-Rb and p130 were easily detectable in 20 g of nuclear extracts from U937V ( Fig. 1b) and A549 (Fig. 1c) cells. For both cell lines, Ad12 E1A wt bound 7-15% of the input (with respect to the amount in nuclear extracts, as calculated from the cell control Western blot signals; Figs. 1, b and c). As shown for Ad5 E1A (Barbeau et al., 1994) , the Ad12 E1A delCR2 mutant that lacks the entire CR2 was unable to bind p105-Rb or p130 (Figs. 1, a and c), underscoring the prominent role of CR2 as pocket protein targeting domain. The E1A Spm1 mutant that lacks the 12 amino-terminal residues of the spacer (Fig. 1a) binds both p130 and p105-Rb as well as E1A wt , indicating that this region is dispensable for efficient binding of Ad12 E1A to p105-Rb and p130. Binding of E1A to p130 also is only little affected when the hydrophobic stretch of six alanines in the carboxyl-terminal half of the spacer are deleted (E1A Spm2 mutant; Fig. 1a ). In contrast, the binding of the E1A Spm2 mutant to p105-Rb was very weak (Figs. 1, b and c) compared with E1A wt or E1A Spm1 . Thus the hexa-alanine stretch in the spacer seems to be required for an efficient binding of Ad12 E1A to p105-Rb.
Influence of the Ad12 E1A spacer mutants on the formation of the p105-Rb-E2F and p130-E2F complexes
To determine whether the binding properties of the spacer mutants to the pocket proteins correspond with the disruption of p105-Rb/p130-E2F complexes, we examined the formation of these complexes in gel shift experiments with the E2F-binding motif from the DHFR promoter in the presence and absence of the E1A proteins (Fig. 2) . For these experiments, 2 g of nuclear extracts from U937V and H596 cells (that do not express p105-Rb; Harbour et al., 1988) were incubated with the [␣-
32 P]dCTP-labeled DHFR-E2F site-containing oligonucleotide.
Four complexes ( Fig. 2A , a-d) are formed in gel shift experiments with the U937V nuclear extracts. Complex b contains p105-Rb and complex a contains p130 as judged from antibody perturbation analysis (Fig. 2A) . The complex c was previously found to contain free E2F-1 . In the case of the p105-Rb-deficient H596 cell line, the most shifted complex contained p130 (Fig. 2B) . The addition of 6 g of the E1A wt protein disrupted both the p105-Rb-containing ( Fig. 2A) and the p130-containing (Figs. 2, A and B) complexes, whereas the E1A delCR2 did not affect any of the complexes (Figs. 2, A and B), supporting the results of the protein interaction experiments (Figs. 1, b and c). As E1A wt , 6 g of both the E1A Spm1 and the E1A Spm2 mutant, respectively, are able to disrupt the p105-Rb-E2F and p130-E2F complex. Because these high amounts of E1A proteins might mask a fine tuning of pocket protein E2F disruption, we examined whether the spacer modulates this E1A function using lower levels of E1A wt , E1A Spm1 , and E1A Spm2 GSTfusion proteins (Fig. 3) . At 0.5 g of GST-E1A protein, disruption of the p105-Rb-containing complex b is incomplete for E1A wt and even less effective for E1A Spm2 . In contrast, the formation of complex b was significantly reduced in the presence of 0.5 g of the E1A Spm1 mutant protein, resulting in a ranking of the order of E1A Spm1 Ͼ E1A wt Ͼ E1A Spm2 (Fig. 3 ). This ranking is observed for as much as 2 g of E1A proteins (data not shown), whereas no difference among the E1A wt , E1A Spm1 , and E1A Spm2 proteins was found at 4 g, even after long exposure of the gel shift (long exposure, Fig. 3 , 4 g*). Efficient disruption of the p130-containing complex a requires Ͼ4 g of E1A proteins (compare Figs. 2A and 3) , possibly due to a preferred interaction of E1A with the p105-Rb-E2F complex. All complexes were efficiently competed by a 10-to 500-fold molar excess of the unlabeled DHFRoligonucleotide, whereas an E2F-1-binding site mutant oligonucleotide [DHFR M ; prepared according to the 62/60 mutant described by LaThangue et al. (1990) ] had no effect on the complex formation, except for complex d, which was unaffected by a 10-fold but diminished by a 100-and 500-fold excess of DHFR M (Fig. 2C) , indicating a lower affinity of the binding partners compared with the other complexes.
In summary, two regions within the Ad12 E1A spacer have disparate effects on the interaction of E1A with the p105-Rb pocket protein: The hexa-alanine stretch contributes to the p105-Rb targeting by E1A (Fig. 1b) and efficiently supports the disruption of p105-Rb-E2F complexes. In contrast, the 12 amino-terminal residues of the spacer do not seem to contribute to the targeting of p105-Rb by E1A (Figs. 1, a and b) and the presence of this region in E1A proteins reduces their ability to disrupt the p105-Rb-E2F complex (Fig. 3) .
The hexa-alanine stretch and the amino-terminal part of the spacer express disparate functions in the transformation of primary mouse cells
To analyze whether the hexa-alanine stretch and the amino-terminal part of the spacer have an effect on E1A functions in vivo, we examined the transformation properties of E1A in cooperation with Ad12 E1B by focus formation analysis (Table 1) . We cotransfected mouse kidney cells prepared from neonatal NMRI mice (days 5-7 after birth) with equal amounts (see Materials and Methods) of the Ad12 or Ad2 E1A and E1B expression constructs or with the pRc/RSV eukaryotic expression vector alone and cultured the cells in 25-cm 2 flasks. The expression of the respective E1A proteins was shown in Western blots, and E1B expression was monitored by RT-PCR (data not shown). The transfected cells were screened for focus formation for as long as 15 weeks.
Except for the E1B control, small foci began to form in all cases after 3 weeks of culture. These early small foci (Ͻ1 mm in diameter), in which single cells could be distinguished, were termed "cell clusters," whereas cell groupings with high numbers of cells, which exhibit three-dimensional growth and were usually Ͼ1 mm in diameter, were termed "foci." The number and size of the early cell clusters increased for 1-3 additional weeks, and some of these clusters were considered as foci 5-6 weeks after transfection (Table 1 ). The number of clusters plus foci for Ad2 E1A wt -or E1A Spm1 -transfected cells was higher (30-40/25 cm 2 ), as in case of the Ad12 E1A wt -, E1A delCR2 -, or E1A Spm2 -transfected cells (3-15/25 cm 2 ). Cells began to spread out from some foci 6-9 weeks after transfection (Table 1) , and some of the larger foci began to detach from the flask surface. At this time, the cultures including all clusters and foci were trypsinized and replated. Trypsinized cells readhered with the Ad2 E1A wt -, Ad12 E1A wt -, E1A Spm1 -, and E1A Spm2 -transfected cells. The replated Ad2 E1A wt -, Ad12 E1A wt -, and E1A Spm1 -transfected cells could be established as cell lines. Interestingly, the E1A Spm1 -and Ad2 E1A wt -expressing cells lines exhibited a more aggressive growth, with doubling rates of 15 and 12 h, respectively, than the Ad12 E1A wtexpressing cells, which grew slowly with a doubling rate of 120 h. Thus removal of the carboxyl-terminal part of the spacer in Ad12 E1A (E1A Spm1 ) results in comparable growth characteristics of the transformed cells as for the wild-type Ad2 E1A wt . In contrast, replated E1A Spm2 -transformed cells exhibited no or only very moderate growth, and cells died within 10-14 weeks after transfection. This indicates that the six alanines in the spacer region of Ad12 E1A are necessary for stable transformation of primary mouse cells. Interestingly, the same region is thought to be essential for the oncogenic properties of E1A, as judged from Ad5/12 hybrid virus experiments (Telling and Williams, 1994; Williams, 1995) .
To examine whether the extent of pocket protein binding by the different E1A proteins in the established mouse kidney cells (BMK) cell lines was comparable to that found in vitro, we analyzed the formation of the p105-Rb-E2F and the p130-E2F complexes by combined immunoprecipitation and Western blotting experiments (see Materials and Methods). We examined immunoprecipitated p105-Rb complexes for coprecipitated E1A proteins with anti-Ad12 E1A and anti-Ad5 E1A antibodies, both of which exhibit cross-reactivity with the E1A proteins from the other species. Due to the different phosphorylation in vivo, two to four bands were detected with both antibodies, where the binding of Ad2 E1A to the p105-Rb protein appeared to be the strongest, followed by the Ad12 E1A Spm1 mutant and the Ad12 E1A wt protein, although the differences in the binding affinity were less prominent when the Ad12 E1A antibody was used (Fig.  4) . In contrast, no significant differences were observed when the complex formation between E1A and the p130 pocket protein was examined (data not shown). Thus in contrast to the in vitro binding assays, a somewhat enhanced binding of E1A Spm1 to p105-Rb was found in the transformed cells compared with E1A wt. However, these findings correlate with the results from the gel shift experiments (Fig. 3) and with the growth characteristics of the transformed cell lines (see Table 1 ).
Taken together, we define two domains in the Ad12
Effects of low E1A protein levels on the disintegration of p105-Rb/p130-E2F complexes. Gel shift experiments were performed as described in Fig. 2 with U937V nuclear extracts in the presence of different amounts (0.5 and 4 g) of GST-E1A (E1A wt , E1A Spm1 , and E1A Spm2 ) fusion proteins. 4 g* indicate long exposure of the gel part, in which 4 g of E1A proteins were used. Numbering of the complexes is as described in Fig. 2A .
E1A unique spacer with opposite abilities in cell transformation: the amino-terminal part of the spacer seems to mediate a less aggressive growth of Ad12 E1-transformed cells, whereas the hydrophobic stretch of six alanines is indispensable for efficient transformation, which corresponds with its importance for the targeting of p105-Rb by Ad12 E1A.
Oligoalanine stretches, as in Ad12 E1A spacer or in other oncogenic Ad like SA7 (Williams, 1995) , are a feature of transcriptional suppressor proteins found in the embryonic development of Drosophila, like the "Krüp-pel" (Kr) zinc finger containing polypeptide (Licht et al., 1990) . Interestingly, the transcriptional repressor functions of Kr map within the alanine-rich amino-terminus of the protein (Licht et al., 1990) . If, however, the hexaalanine stretch in the Ad12 E1A 13S and/or 12S mRNAencoded proteins mediates repression of cellular genes and if such a kind of transcriptional repressor function contributes to the transformation properties of Ad12 E1A remain to be established.
MATERIALS AND METHODS

Cell culture
The A549 small cell lung carcinoma cell line (American Type Culture Collection) was maintained in DMEM, 10% FCS, and 2 mM glutamine. The U937 variant (V) histiocytic lymphoma cell line Kloke et al., 1992) and the non-small lung cancer NCI-H596 cell line (kindly provided by Dr. F. Kaye, National Cancer InstituteNavy Oncology Branch, Bethesda, MD) that lacks b Small foci (Ͻ1 mm in diameter), in which single cells could be distinguished, were termed "cell clusters"; cell crowds of Ͼ 1 mm in diameter that exhibit three-dimensional growth and in which no single cell could be distinguished were termed "foci."
c At 6-9 weeks after transfection, the cultures including all clusters and foci were trypsinized and replated.
p105-Rb expression (Harbour et al., 1988) were cultured in RPMI, 10% FCS, and 2 mM glutamine.
E1A expression constructs
We generated two spacer mutants of the large, 13S mRNA-encoded wild-type E1A protein (E1A wt ), lacking either the amino-terminal (E1A Spm1 ) or the very carboxylterminal part of the spacer consisting of the hydrophobic Ala 6 stretch (E1A Spm2 , Fig. 1A ) by primer-introduced sequence modification PCR as described previously (Kirch et al., 1993) . These mutants, as well as E1A wild type (E1A wt ) and a mutant lacking the CR2 (E1A delCR2 , Fig. 1A ), were cloned into the pGEX-2T[128/129] bacterial expression vector (kindly provided by Dr. M. A. Blanar, Department of Molecular Biology, Princeton University). After IPTG induction of protein synthesis, the amino-terminal glutathione-S-transferase (GST)-E1A fusion proteins were purified by glutathione (GT)-Sepharose chromatography as recently described (Kirch et al., 1998) .
Combined protein interaction Western blot experiments
Purified GT-Sepharose-bound E1A proteins were used for protein interaction/Western blot experiments, in which 50 g of E1A proteins was incubated with 1 mg of twice GT-Sepharose-precleared nuclear extracts that were prepared as described previously and washed three times with the incubation buffer (20 mM HEPES, pH 7.4, 0.1% Tween 20, 1 mM NaF, 1 mM Na 2 VO 3 , 150 mM NaCl). Subsequently, GST-E1A-bound nuclear proteins were eluted by incubation with 120 l of Laemmli's buffer at 95°C for 10 min, containing 5% of ␤-mercaptoethanol, and one fourth of the eluted proteins was analyzed by Western blotting .
Immunoprecipitation
Immunoprecipitation experiments were performed using 100 g of nuclear extracts from the Ad12 E1A wt -, Ad12 E1A Spm1 -, and Ad2 E1A wt -plus E1B-transformed cell lines and the IF8-anti-p105-Rb or the C20-anti-p130 antibodies (Santa Cruz) as described previously (Kirch et al., 1999) . The amount of pocket protein-bound E1A proteins was analyzed by Western blotting using either an anti-Ad12 E1A polyclonal sheep antibody (kindly provided by P. Gallimore, CRC Institute for Cancer Studies, The Medical School, University of Birmingham, UK) or an anti-Ad5 E1A antibody (M73; Santa Cruz).
Gel shift experiments
For gel shift experiments, the binding of proteins from nuclear extracts to the E2F-binding motif from the DHFR promoter was examined in the presence and absence of the (GST)-E1A proteins. For these experiments, 2 g of nuclear extract was incubated with the[␣-
32 P]dCTP-labeled DHFR-E2F site-containing oligonucleotide (5Ј-GGGCTGCGATTTCGCGCCAAACTT-GACGGCA-3Ј) as recently described . For competition experiments, the unlabeled DHFR-E2F site oligonucleotide and an E2F-binding site mutant oligonucleotide [GGGCTGCGATTTCGATA-CAAACTTGACGG, according to the E2F-binding deficient E2-promoter-mutant 62/60, described by La Thangue et al. (1990) ] were used. For antibody perturbation experiments, nuclear proteins were preincubated with either 0.3 g of the IF8-anti-p105-Rb antibody (Santa Cruz) or 2 g of the C20-anti-p130 antibody (Santa Cruz) for 4 h at 4°C before the addition of the oligonucleotide. For E1A interference analysis, 0.5, 4, or 6 g of recombinant E1A protein was incubated with the nuclear proteins for 4 h at 4°C.
Foci formation analysis
Mouse kidney cells were prepared from neonatal NMRI mice (days 5-7 after birth). The cells were transfected, using the FuGENE 6 transfection reagent (Boehringer-Mannheim) according to the manufacturer's protocol, with 0.75 g of pRc/RSV-Ad12-E1B plus 0.75 g of pRc/RSV-Ad12-E1A wt , -E1A Spm1 , -E1A Spm2 , -E1A delCR2 , or -Ad2 E1A or with the pRc/RSV eukaryotic expression vector alone. Cells were cultured in DMEM, 10% FCS, and 2 mM glutamine. Medium was changed twice a week, and foci formation was determined weekly. All experiments were performed in triplicate with 2 ϫ 10 5 cells each.
FIG. 4.
Analysis of E1A-p105-RB complex formation in the established Ad12 E1A wt -, Ad12 E1A Spm1 -, and Ad2 E1A wt -plus Ad12 E1B-transformed baby BMK cells. Immunoprecipitation was performed as described in Materials and Methods using the anti-105-RB antibody. The amount of pocket protein-bound E1A proteins was analyzed by Western blotting using either an anti-Ad12 E1A antibody (*kindly provided by P. Gallimore) or an anti-Ad5 E1A antibody (M73).
